▼ 2.97%
prev close
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
Congressional Trades
2
All tracked trades
Members Trading
1
Unique members
Net Activity
-2
0 buys · 2 sells
Members Who Traded This Stock
2 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2021-02-10 | TLRYTilray, Inc. - Class 2 | Sell | $50,001 - $100,000 | 1391d ago | — | |
| 2021-02-09 | TLRYTilray, Inc. - Class 2 | Sell | $15,001 - $50,000 | 1391d ago | — |
2021-02-10
Brian Mast
TLRY
Amount
$50,001 - $100,000
Filed
1391d ago
2021-02-09
Brian Mast
TLRY
Amount
$15,001 - $50,000
Filed
1391d ago
Recent News
Powered by Polygon.io
Glioblastoma Multiforme Market Poised for Significant Growth at a CAGR of 13.2% During the Forecast Period (2026–2036), as Next-Generation Therapies Enter Late-Stage Development | DelveInsight
BrewDog Turns This Summer’s Global Football Tournament into a Nationwide Celebration of Beer, Bars and Big Match Moments
Tilray Looks Ready for a Breakout -- If 1 Thing Goes Right
Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now
AI Technology Transforms Cannabis Industry as Leading Operators Drive Adoption to Enhance Yields and Compliance
Trade Timeline
Congressional activity, newest first
Brian Mast
2021-02-10 · Sale
$50,001 - $100,000
Brian Mast
2021-02-09 · Sale
$15,001 - $50,000